ARCHIVES

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

Bennett, CCIRC Members Disagree On state Of Groups, Simons New Chairman

June 27, 1980

Weicker Compromise on 6,000 Grants For Two Years Holds Up; New Waxman Bill Would Renew Cancer Act

May 17, 1985

SPOREs In Breast, Prostate Cancers Win $12.7 Million.

October 6, 2000

Nobelist Offer “Electronic” Theory Of Cancer

June 27, 1975

Group Chairmen Object To “Directive” Language In Proposed Intergroup Study Guidelines

January 13, 1984

White House Order Poses Difficulties For NIH Peer Review

April 2, 1993